|
Volumn 212, Issue 4, 2000, Pages 196-199
|
Neurotrophin receptor TrkC predicts good clinical outcome in medulloblastoma and other primitive neuroectodermal brain tumors
a,b b b c |
Author keywords
Brain tumor; Medulloblastoma; PNET; Prognosis
|
Indexed keywords
MESSENGER RNA;
NEUROTROPHIN RECEPTOR;
PROTEIN TYROSINE KINASE;
ADOLESCENT;
ARTICLE;
CANCER SURVIVAL;
CHILD;
CONTROLLED STUDY;
FEMALE;
HUMAN;
HUMAN TISSUE;
IN SITU HYBRIDIZATION;
INFANT;
MAJOR CLINICAL STUDY;
MALE;
MEDULLOBLASTOMA;
NEUROECTODERM TUMOR;
PREDICTION;
PRESCHOOL CHILD;
PROGNOSIS;
PROTEIN EXPRESSION;
REGRESSION ANALYSIS;
SCHOOL CHILD;
ADOLESCENT;
ADULT;
BRAIN NEOPLASMS;
CHILD;
CHILD, PRESCHOOL;
DISEASE-FREE SURVIVAL;
FEMALE;
GENE EXPRESSION REGULATION, NEOPLASTIC;
HUMANS;
IN SITU HYBRIDIZATION, FLUORESCENCE;
INFANT;
MALE;
MEDULLOBLASTOMA;
NEUROECTODERMAL TUMORS, PRIMITIVE;
PREDICTIVE VALUE OF TESTS;
PROPORTIONAL HAZARDS MODELS;
RECEPTOR, TRKC;
RETROSPECTIVE STUDIES;
RNA, MESSENGER;
SURVIVAL ANALYSIS;
TUMOR MARKERS, BIOLOGICAL;
|
EID: 0033843435
PISSN: 03008630
EISSN: None
Source Type: Journal
DOI: 10.1055/s-2000-10044 Document Type: Article |
Times cited : (41)
|
References (18)
|